These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3258298

  • 1. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
    Walling J, Stratford IJ, Adams GE, Stephens MA.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr; 53(4):641-9. PubMed ID: 3258298
    [Abstract] [Full Text] [Related]

  • 2. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
    Walling JM, Stratford IJ, Adams GE, Silver AR, Ahmed I, Jenkins TC, Fielden EM.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
    [Abstract] [Full Text] [Related]

  • 3. High uptake of RSU 1069 and its analogues melanotic melanomas.
    Walling JM, Deacon J, Holliday S, Stratford IJ.
    Cancer Chemother Pharmacol; 1989 Jul; 24(1):28-32. PubMed ID: 2541936
    [Abstract] [Full Text] [Related]

  • 4. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S, Stratford IJ, Adams GE, Fielden EM, Jenkins TC.
    Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [Abstract] [Full Text] [Related]

  • 5. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
    Austen KR, Jenner TJ, O'Neill P, Fielden EM.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
    [Abstract] [Full Text] [Related]

  • 6. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
    Ahmed I, Jenkins TC, Walling JM, Stratford IJ, Sheldon PW, Adams GE, Fielden EM.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
    [Abstract] [Full Text] [Related]

  • 7. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
    Jenner TJ, O'Neill P, Crump PW, Fielden EM, Sapora O, Santodonato L.
    Biochem Pharmacol; 1991 Oct 09; 42(9):1705-10. PubMed ID: 1930296
    [Abstract] [Full Text] [Related]

  • 8. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
    Adams GE, Ahmed I, Sheldon PW, Stratford IJ.
    Br J Cancer; 1984 May 09; 49(5):571-7. PubMed ID: 6547051
    [Abstract] [Full Text] [Related]

  • 9. The effect of extracellular pH on radiosensitization by misonidazole and acidic or basic analogues.
    Watts ME, Jones NR.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun 09; 47(6):645-53. PubMed ID: 3873434
    [Abstract] [Full Text] [Related]

  • 10. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
    Adams GE, Ahmed I, Sheldon PW, Stratford IJ.
    Int J Radiat Oncol Biol Phys; 1984 Sep 09; 10(9):1653-6. PubMed ID: 6548211
    [Abstract] [Full Text] [Related]

  • 11. Oncogenic transforming potential of nitroimidazole radiosensitizers.
    Hall EJ, Hei TK.
    Int J Radiat Oncol Biol Phys; 1989 May 09; 16(5):1231-4. PubMed ID: 2523882
    [Abstract] [Full Text] [Related]

  • 12. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
    Roizin-Towle L, Pirro JP, Hall EJ.
    Radiat Res; 1990 Oct 09; 124(1 Suppl):S50-5. PubMed ID: 2236511
    [Abstract] [Full Text] [Related]

  • 13. The phosphate-group of DNA as a potential target for RSU-1069, a nitroimidazole-aziridine radiosensitizer.
    Silver AR, O'Neill P, Jenkins TC, McNeil SS.
    Int J Radiat Oncol Biol Phys; 1986 Jul 09; 12(7):1203-6. PubMed ID: 3755715
    [Abstract] [Full Text] [Related]

  • 14. Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential.
    Hei TK, He ZY, Piao CQ, Hall EJ.
    Radiat Res; 1990 Oct 09; 124(1 Suppl):S44-9. PubMed ID: 2236509
    [Abstract] [Full Text] [Related]

  • 15. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1989 Apr 09; 16(4):1115-8. PubMed ID: 2703392
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.
    Walton MI, Workman P.
    Cancer Chemother Pharmacol; 1988 Apr 09; 22(4):275-81. PubMed ID: 3168141
    [Abstract] [Full Text] [Related]

  • 17. Experimental pharmacokinetics of RSU-1069 and its analogues: high tumor/plasma ratios.
    Deacon JM, Holliday SB, Ahmed I, Jenkins TC.
    Int J Radiat Oncol Biol Phys; 1986 Jul 09; 12(7):1087-90. PubMed ID: 3755713
    [Abstract] [Full Text] [Related]

  • 18. Studies on the toxicity of RSU-1069.
    Whitmore GF, Gulyas S.
    Int J Radiat Oncol Biol Phys; 1986 Jul 09; 12(7):1219-22. PubMed ID: 3755716
    [Abstract] [Full Text] [Related]

  • 19. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
    Keohane A, Godden J, Stratford IJ, Adams GE.
    Br J Cancer; 1990 May 09; 61(5):722-6. PubMed ID: 2110815
    [Abstract] [Full Text] [Related]

  • 20. Radiosensitization by misonidazole, pimonidazole and azomycin and intracellular uptake in human tumour cell lines.
    Watts ME, Dennis MF, Roberts IJ.
    Int J Radiat Biol; 1990 Feb 09; 57(2):361-72. PubMed ID: 1968500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.